Cleven 2000 Anti-Xa IU/0.2 ml (SC Injection)

0.2 ml pre-filled syringe: ৳ 250.00

Medicine Details

Category Details
Generic Enoxaparin sodium
Company Beximco pharmaceuticals ltd
Also available as
Cleven 4000 anti xa injection Cleven 6000 anti xa injection Cleven 8000 anti xa injection

Title

Cleven Enoxaparin Sodium Injection

Categories

  • Medicine
  • Healthcare
  • Pharmaceutical

Description

Cleven Enoxaparin Sodium Injection is indicated for the treatment of deep vein thrombosis, with or without pulmonary embolism; unstable angina and non-Q-wave myocardial infarction; prevention of thrombus formation during hemodialysis; prophylaxis of venous thromboembolic disease in surgical and medical patients.

Attributes

  • Volume Options:
    • 0.2 ml
    • 0.4 ml
    • 0.6 ml
    • 0.8 ml
  • Enoxaparin Sodium Content: 20 mg, 40 mg, 60 mg, 80 mg
  • Anti-Xa Activity: 2000, 4000, 6000 IU
  • Pharmacology: Low molecular weight heparin with high anti-Xa activity and low anti-IIa activity
  • Metabolism: Primarily metabolised in the liver
  • Dosage Forms:
    • Pre-filled Syringes
  • Dosage Administration: Subcutaneous injection
  • Dosage Instructions: Varies based on indications and patient conditions
  • Injection Site Preparation: Instructions for preparing the injection site
  • Dose Selection: Instructions for selecting the correct dose
  • Usage Instructions: Step-by-step guide for self-injection
  • Contraindications:
    • Hypersensitivity to Enoxaparin Sodium
    • Active major bleeding
    • High risk of uncontrolled hemorrhage
  • Side Effects:
    • Haemorrhage
    • Thrombocytopenia
    • Elevated serum aminotransferase
    • Pain at injection sites
    • Skin rash at injection sites
  • Pregnancy Category: Category B
  • Pregnancy Precautions: Use only if clearly needed
  • Lactation Precautions: Consider potential risks to the infant
  • Precautions: Use with caution in conditions with increased bleeding potential
  • Special Population Dosing: Instructions for elderly, renal impaired, and hepatically impaired patients
  • Overdose Effects: Hemorrhagic complications
  • Neutralization: Slow i.v. injection of protamine sulfate
  • Therapeutic Class: Parenteral anti-coagulants
  • Storage Conditions: Cool, dry place; protect from light and moisture; do not refrigerate or freeze; keep out of reach of children
  • Interaction Cautions: Discontinue agents affecting hemostasis prior to Cleven therapy
  • Technical Information: Content of anti-Xa activity in each dosage form
  • Instructions for Use: Step-by-step guide for administering the injection
  • Drug Storage: Temperature and moisture conditions for storage
  • Drug Disposal: Instructions for discarding used syringes
  • Hemorrhagic Risk: Considerations for conditions with high bleeding potential
  • Platelet Count Monitoring: Recommendations for monitoring platelet counts during treatment

Related Brands